Search

Search Constraints

You searched for: Author/Creator Havervall, Sebastian

Search Results

11. Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report. Issue 2 (February 2021)

13. Prothrombotic changes in patients with COVID‐19 are associated with disease severity and mortality. Issue 1 (6th December 2020)

14. Response by Mackman et al to Letter Regarding Article, "Patients With COVID-19 Have Elevated Levels of Circulating Extracellular Vesicle Tissue Factor Activity That Is Associated With Severity and Mortality—Brief Report". Issue 6 (27th May 2021)

15. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID‐19. (27th September 2021)

16. Soluble angiotensin‐converting enzyme 2 is transiently elevated in COVID‐19 and correlates with specific inflammatory and endothelial markers. Issue 10 (6th July 2021)

17. Systematic evaluation of SARS‐CoV‐2 antigens enables a highly specific and sensitive multiplex serological COVID‐19 assay. Issue 7 (19th July 2021)